Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry.

Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training.

Top 5 learnings from the episode:

1. The critical need for data sharing in the pharmaceutical industry and how it can foster innovation. 
2. The concerning lack of representation of non-white individuals in clinical trials and the reasons behind this disconnect. 
3. The importance of analyzing claims data and site-specific data to uncover the underlying issues affecting patient enrollment in clinical trials. 
4. The crucial role of healthcare access, implicit bias, and community engagement in empowering underrepresented populations. 
5. The steps being taken by pharmaceutical companies and society to drive diversity, equity, and inclusion in healthcare.

Tune in to this eye-opening episode of Pharma Sessions and be part of the movement to advance health equity, bridge the gaps in clinical trials and physician training, and ensure that all patients receive the care they deserve.

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com

Pharma Sessions is hosted by Jonathan Kaskey

Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

Or join the Pharma Sessions Substack:
www.pharmasessions.substack.com